A Phase 2 Study of E6005 in Patients With Atopic Dermatitis
Status:
Completed
Trial end date:
2013-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and safety profiles of E6005 ointment
in patients with atopic dermatitis compared to vehicle. The pharmacokinetic profile after
topical application of E6005 is also assessed.